asthma and COPD News
-
Vitalograph introduces tremoflo C-100 oscillometer to its extensive range of respiratory diagnostic solutions
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, in Washington. Developed in partnership with Thorasys, the Vitalograph tremoflo® C-100 oscillometer helps to detect the presence of small airway impairment, providing ...
-
SpiroSonic AIR Approved for European CE Mark
Patent protected wireless lung function testing technology, Asthma, COPD, and post-COVID syndrome, Spirometry market is predicted to double in 12 months, Globalisation initiative – Europe, SE Asia and the US. Uscom notifies the market of notice to approve CE mark for the Uscom digital ultrasonic SpiroSonic AIR spirometer. The CE mark is recognition of legal compliance with health, safety ...
By Uscom Ltd
-
Alex MacKerell, PhD, SilcsBio Co-founder & CSO, Co-Leads Study on Use of SILCS Technology to Improve Lung Disease Treatments
December 14, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced its Co-Founder and Chief Scientific Officer, Alexander D. MacKerell Jr., PhD, has co-led a study focusing on improving respiratory treatments via SilcsBio’s Site Identification by Ligand Competitive Saturation (SILCS) ...
-
Lung Cancer Awareness Month and the Importance of Protecting Workers from All Types of Respirable Hazards
November is recognized as Lung Cancer Awareness Month and in the United States, as in many other parts of the world, more people die from this disease than from any other type of cancer. In the U.S. alone, approximately 200,000 people are told they have lung cancer and more than 150,000 die from the disease annually. Globally, the World Health Organization (WHO) reports that lung cancer has been ...
-
VIDA appoints digital health technology leader Karen Drexler to board of directors, underscoring focus on market expansion of AI solutions
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it is has appointed Karen Drexler to its board of directors, further expanding the company’s leadership strength in digital health technology. Drexler’s appointment comes at a critical time in healthcare, as the world continues to address the potential long-term lung ...
-
Sommetrics Selected to Present at the Respiratory Innovation Summit
SAN DIEGO, Calif. — MAY 14, 2019 — Sommetrics, a company providing products and services to improve sleep quality, today announced it has been selected to be one of five companies to present at the airways symposium of the Respiratory Innovation Summit in Dallas on May 17, 2019. This Summit is a yearly event held in advance of the American Thoracic Society’s International ...
By Sommetrics
-
Biomark to present validation data of its multianalyte metabolite panel for lung cancer screening at the esmo congress 2022
Vancouver, British Columbia – (September 8, 2022) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that it’s abstract titled “Metabolomic Profiling for the Early Detection of Lung Cancer” has been ...
-
Pollen, Mold and Other Indoor Contaminants Impact Puerto Rico’s Allergy and Asthma Rates
Allergy and asthma rates in Puerto Rico are much higher than most other parts of the United States. There are a number of factors for why this is likely the case, including the region’s tropical climate which is conducive for the growth of mold and year-round pollen. Flowering plants, trees and grasses release pollen into the environment. The fine powdery substance can be carried by the ...
-
Showcase
AioCare system could be successfully applied in primary healthcare Centers.
The role of spirometry in diagnosing and monitoring chronic obstructive airway diseases is crucial. According to WHO, the demonstration of irreversible airway obstruction is essential for diagnosing chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide. It is estimated that up to 67–81% of patients with COPD remain undiagnosed. Mobile phone-linked ...
By AioCare
-
Allergy Prevention Tips for Healthy Homes and Offices in Puerto Rico
For most people, the majority of their time is spent at home and at their place of business. For those with allergies, both of these indoor environments can often be a source of allergens that cause or aggravate their condition. Millions of people have respiratory allergies, asthma or COPD. Exposure to common indoor allergens such as mold, dust mites, latex, pollen, pets, rodents and cockroaches ...
-
Biomark provides business update and second quarter financial results
Vancouver, British Columbia – (November 28, 2022) – BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to reports that it will amend the term of the non-broker warrants (the “Warrants”) issued in relation to ...
-
VIDA Introduces New AI-Enabled Biomarker Services
VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence data, is introducing a new suite of retrospective data analysis services for clinical trial sponsors in response to growing demand for precision data to optimize lung treatment trials. Announced at the 2022 American Thoracic Society (ATS) International Conference, this suite of services empowers sponsors to leverage ...
-
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Stemedica Cell Technologies, Inc. (“Stemedica”), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced today that it has signed a Licensing Agreement with Pulthera, LLC for the rights to use, distribute and sell its mesenchymal stem cell technologies in the treatment of COVID-19 and additional pulmonary conditions. The agreement was ...
-
Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ
Ocean Biomedical’s innovative business model bridges the ‘bench-to-bedside’ gap by accelerating the commercialization of innovative assets from research universities and medical centers. Ocean Biomedical’s initial core portfolios in oncology, fibrosis, and infectious diseases – all based on new target discoveries enabling first-in-class drug and vaccine ...
-
Vitalograph introduces tremoflo C-100 oscillometer to its extensive range of respiratory diagnostic solutions
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...
-
Feldan therapeutics announces a publication in nature communications
In an article published in Nature Communications, entitled "Engineered Amphiphilic Peptides Enable Delivery of Proteins and CRISPR Associated Nucleases to Airway Epithelia” Dr. David Guay, Research Director of Feldan Therapeutics, and collaborator Dr. Paul McCray, from the University of Iowa Carver College of Medicine, demonstrate that Feldan’s engineered amphiphilic peptides (Feldan ...
-
VIDA, UnityPoint Health join forces to modernize lung and respiratory care with agreement to implement AI-powered lung intelligence solutions across the UnityPoint Health system
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it has signed an agreement with UnityPoint Health to implement VIDA’s AI-powered lung intelligence and imaging solutions across the UnityPoint Health system. UnityPoint Health is one of the nation’s leading integrated delivery networks, with 21 hospitals and more than ...
-
Dynamic Air Quality Solutions announces Partnership with COPD Foundation
Dynamic Air Quality Solutions, a manufacturer and distributor of high-performance indoor air quality products, announced today that it is partnering with the COPD Foundation to help increase awareness about Chronic Obstructive Pulmonary Disease (COPD) and to improve the lives of an estimated 30 million people living with COPD in North America. COPD is the 3rd leading cause of death in North ...
-
Puerto Rico Recognizes Lung Cancer Awareness Month and Steps to Prevent Exposure to Carcinogens
More people in the United States die from lung cancer than due to any other type of cancer according to the Centers for Disease Control and Prevention (CDC). This fact is true for both men and women as more than 150,000 die from the disease each year in the U.S. as approximately 200,000 people are told they have lung cancer. These numbers represent family members and friends and helps to ...
-
Fluidda and Aptar Pharma Exclusive Collaboration
Fluidda, leader in the field of Functional Respiratory Imaging and developer of the medical device Broncholab®, today announced an exclusive collaboration with Nanopharm, an Aptar Pharma company and a leader in contract research and development services for orally inhaled and nasal drug products (OINDPs). The companies will leverage their respective proprietary technology platforms to help ...
By Fluidda
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you